Patents by Inventor Marie-Aline Bloch

Marie-Aline Bloch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Virus-like particles useful as a vector for delivering nucleic acid
    Patent number: 6420160
    Abstract: The present invention relates to the use of virus-like particles (VLP's) of papillomavirus for preparing vector pseudoviruses useful for transferring genetic material into target cells of an organism
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: July 16, 2002
    Assignee: Pasteur Merieux Serums et Vaccins
    Inventor: Marie-Aline Bloch
  • Transferrin receptor subunit proteins of Neisseria meningitidis
    Patent number: 6326350
    Abstract: The subject of the present invention is a DNA fragment which encodes a protein capable of being recognised by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis as well as a process for producing the said protein by a recombinant route. By way of example, such a DNA fragment encodes the tbp1 subunit of the strain IM2394 or IM2169 or the tbp2 subunit of the strain IM2394 or IM2169.
    Type: Grant
    Filed: June 3, 1997
    Date of Patent: December 4, 2001
    Assignees: Pasteur Merieux Serums et Vaccins, Transgene, S.A.
    Inventors: Eric Jacobs, Michèle LeGrain, Véronique Mazarin, Bernadette Bouchon-Theisen, Anthony B. Schryvers, Marie-Aline Bloch
  • Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis
    Patent number: 6028049
    Abstract: The subject of the present invention is a DNA fragment which encodes a protein capable of being recognised by an antiserum against the transferrin receptor of the strain IM2394 or IM2169 of N. meningitidis as well as a process for producing the said protein by a recombinant route. By way of example, such a DNA fragment encodes the tbp1 subunit of the strain IM2394 or IM2169 or the tbp2 subunit of the strain IM2394 or IM2169.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: February 22, 2000
    Assignees: Pasteur Merieux Serums et Vaccins, Transgene S.A.
    Inventors: Eric Jacobs, Michele Legrain, Veronique Mazarin, Bernadette Bouchon-Theisen, Anthony B. Schryvers, Marie-Aline Bloch